ETF PRO AINovember 17, 2026
CANC Tema Oncology ETF
Fund tearsheet · data as of the latest session · November 17, 2026
ONE YEAR OF DAILY CLOSES
0.99%expense ratio
$51Mfund assets
+16.0%return, YTD
—return, 1 year
—net flow, 1 month
—net flow, 1 year
24.3%realized volatility, 1y
-13.2%worst drawdown, 1y
Top ten holdings
| 1 | GMAB GENMAB A | 5.82% |
| 2 | LLY ELI LILLY | 5.62% |
| 3 | RVMD REVOLUTION MEDICINES | 5.34% |
| 4 | MRK MERCK & CO | 5.03% |
| 5 | ONC BeiGene | 4.34% |
| 6 | COGT COGENT BIOSCIENCES | 4.31% |
| 7 | ABBV ABBVIE | 3.88% |
| 8 | EXEL EXELIXIS | 3.74% |
| 9 | CGON CG ONCOLOGY INC | 2.89% |
| 10 | BBIO BRIDGEBIO PHARMA | 3.20% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS